Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kevin Watt, MD
Duke Medical Center/Duke Clinical Research Institute
Principal Investigator - Michael J Smith, MD
University of Louisville
Principal Investigator - P. Brian Smith, MD, MHS, MPH
Duke Medical Center/Duke Clinical Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ann and Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Children'S Mercy Hospital
Kansas City, Kansas, United States
- University of Louisville
Louisville, Kentucky, United States
- Akron Children'S Hospital
Akron, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2013
- Primary completion
- 31 Aug 2014
- Completion
- 31 Aug 2014
- Last update posted
- 29 Nov 2016
- Registered enrollment
- 22
- Registry id
- NCT01744730
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.